DEA indicates along with SAMHSA that it will review comments received in response to the March 2023 Proposed Rules, conduct a thorough evaluation of regulatory alternatives, and issue one or more final rules based on the March 2023 Proposed Rules prior to 11 November 2023
The Drug Enforcement Agency released Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications. They have extended COVID-19 waivers for prescribing controlled substances via telemedicine until November 11, 2023.
Executive Summary - The Drug Enforcement Administration (DEA) issued a temporary rule (Temporary Rule), effective 11 May 2023, extending flexibilities regarding the prescribing of.
The US Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) are extending telehealth flexibilities that allow providers to.
On May 10, 2023, the Drug Enforcement Agency (DEA) released a new regulation – “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” –.